EPCAM and pancreatic adenocarcinoma: In contrast to ours and these other previously published results, co-expression of EpCAM and Claudin-7 in human embryonic kidney (HEK) cells and in rat pancreatic adenocarcinoma (AS) cells increases ERK activity and cell migration [6].